Andson Biotech is an Atlanta-based biotechnology company that builds microfluidic tools for mass spectrometry sample preparation. Its DynaChip X1 platform removes salts, detergents, and other interferences while supporting rapid buffer exchange and active sample treatment. The company positions its system for biopharma, advanced therapeutics, and analytical discovery workflows.
Founder, CEO
Andson Biotech primarily focuses on the biotechnology industry, specializing in advanced biotherapeutics and tools for drug discovery and development, particularly in mass spectrometry workflows.
Business model focuses on advanced bioanalytical systems; revenue from product sales and funding.
Andson Biotech operates in the biotherapeutics and mass spectrometry market, where it faces competition from several notable companies. The main competitors include:
Agilent Technologies, Inc.
Thermo Fisher Scientific, Inc.
Danaher Corporation
PerkinElmer, Inc.
Halo Labs
Iroko Pharmaceuticals
Andson Biotech differentiates itself through its specialized focus on mass spectrometry solutions that streamline sample preparation, which is crucial for enhancing drug discovery processes. This niche focus may provide advantages in terms of efficiency and effectiveness in research applications compared to broader competitors.